Oral Antiplatelet Therapy in the Secondary Prevention of Atherothrombotic Events

ISSN： 1175-3277

Source： American Journal of Cardiovascular Drugs, Vol.9, Iss.3, 2009-05, pp. : 197-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Therapy in Atherothrombotic Cardiovascular Diseases for Primary and Secondary Prevention: A Focus on Old and New Antiplatelet Agents

Current Pharmaceutical Design, Vol. 18, Iss. 6, 2012-02 ,pp. : 850-860

Bentham Science Publishers

Access to resources Recommend Favorite

Oral Antiplatelet Therapy in Secondary Prevention of Cardiovascular Events: An Assessment from the Payer's Perspective

By Heeg Bart

PharmacoEconomics, Vol. 25, Iss. 12, 2007-01 ,pp. : 1063-1082

Adis International

Access to resources Recommend Favorite

Antiplatelet therapy in secondary stroke prevention

By Crawford K Michelle Talbert Robert L

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 10, 2001-10 ,pp. : 1609-1613

Informa Healthcare

Access to resources Recommend Favorite

The Role of Oral Antiplatelet Agents in Atherothrombotic Disease

By Ferguson James J.

American Journal of Cardiovascular Drugs, Vol. 6, Iss. 3, 2006-01 ,pp. : 149-157

Adis International

Access to resources Recommend Favorite

Acute Ischemic Cerebrovascular Events on Antiplatelet Therapy: What is the Optimal Prevention Strategy?

Current Pharmaceutical Design, Vol. 19, Iss. 21, 2013-06 ,pp. : 3788-3794

Bentham Science Publishers

Access to resources Recommend Favorite